Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.69 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | F12 | P00748 | 1/20 | 0.48 |
| ▸ | F11 | P03951 | 1/20 | 0.48 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.45 |
| ▸ | CA4 | P22748 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30526047 | 1.00 | MGLL (0.69) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL22646624 | 0.98 | MGLL (0.72) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL24618481 | 0.97 | MGLL (0.70) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL30472537 | 0.97 | MGLL (0.70) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL23441721 | 0.97 | MGLL (0.70) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL15754521 | 0.96 | MGLL (0.68) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL29617333 | 0.96 | MGLL (0.68) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL18374495 | 0.93 | MGLL (0.69) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL23406892 | 0.93 | MGLL (0.75) | MGLLPLGF12F11KLKB1 | |
| SCHEMBL32673209 | 0.93 | MGLL (0.69) | MGLLPLGF12F11KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127285-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2022-04-28 | — | — | US | disclosed |
| WO-2021132956-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2021-07-01 | — | — | WO | disclosed |
| CN-112480171-A | Triazinyl derivative organic electron transport material and preparation method and application thereof | 华南理工大学 | 2021-03-12 | — | — | CN | disclosed |
| WO-2020148243-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-07-23 | — | — | WO | disclosed |
| CN-110709387-A | Novel cyclic compound and organic light emitting device using the same | 株式会社LG化学 | 2020-01-17 | — | — | CN | disclosed |
| WO-2019194594-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2019-10-10 | — | — | WO | disclosed |
| WO-2017111439-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 주식회사 두산 | 2017-06-29 | — | — | WO | disclosed |
| WO-2017105106-A1 | ORGANIC COMPOUND, AND ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING SAME | 주식회사 두산 | 2017-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127285-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | PIEZO1, LEF1, L1CAM | MGLL 3429/4885PLG 4565/4885F12 335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.